Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets
Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.